Corporate Liability from Employee Diversion: Costly on Many Fronts
FDA Law Blog
JUNE 22, 2022
It was alleged that other employees administered the medication to patients even after observing signs of tampering, although no patients were reported harmed. The Pharmacist-in-Charge (“PIC”) or DEA-designate is required to certify they have completed the evaluation and document any corrective action.
Let's personalize your content